503A Vs. 503B Compounding Pharmacies: Similarities & Differences 503B Compounding Master Guide What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines BPC 157 SolXGenix The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group